Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial.

Rejnmark L, Gosmanova EO, Khan AA, Sprague S, Shoback DM, Kohlmeier L, Rubin MR, Palermo A, Schwarz P, Gagnon C, Tsourdi E, Takeuchi Y, Makita N, Imanishi Y, Gittoes N, Díez JJ, Prot-Bertoye C, Lai B, Zhao C, Ukena J, Makara MA, Sibley CT, Shu AD